Results 241 to 250 of about 127,720 (302)

Spatial analysis reveals the evolving organization of IDH-mutant glioma. [PDF]

Cancer Cell
Hoefflin R, Greenwald AC, Galili Darnell N, Mount CW, Tiomkin Y, Gonzalez Castro LN, Wen Z, Simkin D, Patterson AB, Goliand I, Golani O, Fellus-Alyagor L, Cohen M, Joseph K, Beck J, Ravi VM, Kedmi M, Keren-Shaul H, Weller M, Addadi Y, Neidert MC, Suvà ML, Tirosh I.   +22 more
europepmc   +1 more source

Molecular characteristics of isocitrate dehydrogenase 1 R132C-mutant diffuse gliomas: association with TP53 alterations and Li-Fraumeni syndrome. [PDF]

Acta Neuropathol Commun
Yamashita S, Matsumoto F, Saito K, Hidaka M, Arikawa S, Kawano T, Kawano T, Tamura M, Okuyama H, Higa N, Hanaya R, Akahane T, Tanimoto A, Sato Y, Okita Y.   +14 more
europepmc   +1 more source

Role of CXCR4 PET Imaging for the Evaluation of Gliomas: A Comprehensive Literature Review. [PDF]

Cancers (Basel)
Dondi F, Bellini P, Cossandi M, Rinaldi R, Camoni L, Tomasoni F, Statuto M, Viganò GL, Bertagna F.   +8 more
europepmc   +1 more source

Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology. [PDF]

J Neurooncol
Carriere PP, Haisraely O, Aaroe A, Ahmed K, Lewis R, Colson-Fearon D, Bolden M, Swanson TA, Beckham TH, Wang C, De B, Perni S, Tom MC, Li J, McGovern S, McAleer MF, Ghia A, Jiang W, Chung C, Grosshans D, Ballester L, Esquenazi Y, Kamiya-Matsuoka C, Yeboa DN.   +23 more
europepmc   +1 more source

The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas-Feasibility of a Novel Neurocognitive Test Battery. [PDF]

NeuroSci
Gallert SM, Taube J, Potthoff AL, Zeyen T, Borger V, Hamed M, Surges R, Vatter H, Helmstaedter C, Schneider M.   +9 more
europepmc   +1 more source

SOX10 distinguishes oligodendrogliomas from low-grade glioneuronal tumors/low-grade gliomas with oligodendrocyte-like features. [PDF]

J Pathol Clin Res
Zhou D, Hu X, Wang Y, Tang F, Du Z, Xiong J.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Radiogenomics of Gliomas

Radiologic Clinics of North America, 2021
The 2016 World Health Organization brain tumor classification is based on genomic and molecular profile of tumor tissue. These characteristics have improved understanding of the brain tumor and played an important role in treatment planning and prognostication.
Chaitra, Badve, Sangam, Kanekar
openaire   +2 more sources

Multiple gliomas

Voprosy neirokhirurgii imeni N.N. Burdenko, 2022
The authors present 2 patients. One of them had typical multifocal primary multiple synchronous wild-type IDH1/2 glioblastoma subtype RTK1, chromosome 7 duplication, homozygous CDKN2A deletion and chromosome 10 deletion. In another patient, the nature of tumors remains debatable.
M.V. Ryzhova, S.A. Galstyan, E.N. Telysheva, E.I. Petrova, G.L. Kobyakov, A.I. Khodzhaev, S.A. Maryashev   +6 more
openaire   +2 more sources

Malignant gliomas

Current Neurology and Neuroscience Reports, 2004
Malignant gliomas are the most common type of primary brain tumor. Although therapy for patients with these tumors remains limited, there has been important progress recently. In this review, some of these advances are discussed, with an emphasis on targeted molecular therapies.
Patrick Y, Wen, Santosh, Kesari
openaire   +2 more sources